tm logo
SEQ TECH
REGISTERED

on 30 Aug 2024

Last Applicant/ Owned by

PRO BONO BIO ENTREPRENEUR LIMITED

4th Floor, Reading Bridge House,George StreetReading RG1 8LS

GB

Serial Number

2092548 filed on 16th Oct 2020

Registration Number

TMA1253560 registered on 30th Aug 2024

Registration expiry Date

16th Oct 2030

Correspondent Address

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

SEQ TECH

Trademark usage description

lipids and surfactants for use in industry and science, namely, chemical preparations for use in the manufacture of pharmaceuticals and cosmetics; sur Read More

Classification Information


Class [001]
Lipids and surfactants for use in industry and science, namely, chemical preparations for use in the manufacture of pharmaceuticals and cosmetics; surfactants and lipids for use in personal care products; chemical products for in vitro or in vivo use in research and development, namely, in vitro diagnostic reagents for scientific purposes; active chemical ingredients for use in the manufacture of cosmetics; active chemical ingredients for use in the of manufacture of pharmaceuticals and skincare preparations.


Classification kind code

11

Class [003]
Non-medicated toiletries, namely, shower gel, body soap, body wash, shaving soap, facial cream, moisturising cream and shower cream; skin care preparations; face cleansers; cosmetic preparations for skin care; Serum, namely, facial serums, hair serums, anti-aging serums, and beauty serums; beauty balms; skin balms; skin toners; exfoliators, namely, exfoliating creams and scrubs for cosmetic purposes; eye masks for cosmetic purposes, eye cooling masks and gel eye masks; face masks; cosmetic facial toners, non-medicated skin toners, toners for cosmetic use; skin cream, oils, lotions and sprays; skin conditioners; Moisturisers, namely, skin moisturisers, body moisturizers, anti-ageing moisturizers, and cosmetic facial moisturizers; eye cream; eye gel; lip moisturisers; lip balm; hand cream; body lotions; body washes; foot balms; body scrubs; toiletry kits and skin care kits comprised of non-medicated toiletries, namely, shower gel, body soap, body wash, shaving soap, and shower cream, skin care preparations, facial cleansers, cosmetic preparations for skin care, beauty balms, skin balms, skin toners, skin cream, lotions, namely, bath lotions, beauty lotions, body lotions, body and hair sprays and hair conditioners; essential oils for personal use; fragrances; Cosmetic soap; hair care preparations; dentifrices; cosmetics.


Classification kind code

11

Class [005]
Pharmaceutical preparations and substances for the treatment of diseases in the fields of oncology, cardiovascular disease, respiratory disease, gastro-intestinal diseases, osteoarthritis, rheumatism, inflammatory diseases, namely inflammatory joint diseases, inflammatory skin diseases, inflammatory diseases affecting articulating cartilage, connective tissues, tendons and ligaments, inflammatory diseases of muscle tissues, inflammatory diseases of the eyes, inflammatory diseases of the middle and inner ear, inflammatory diseases of the nasal and paranasal passages and sinuses, single gene disorders, bone and blood diseases, reproductive system disorders, asthma, atopic eczema, psoriasis, bronchospasm, venous thrombotic disorders, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal toxicity disease, Alzheimer's disease, gout and macular degeneration, and fungal infection; chemical preparations for pharmaceutical purposes, namely vesicles for in vivo use; diagnostic preparations and substances, all for in vivo use in the fields of oncology, cardiovascular disease, respiratory disease, gastro-intestinal diseases, osteoarthritis, rheumatism, inflammatory diseases, namely inflammatory joint diseases, inflammatory skin diseases, inflammatory diseases affecting articulating cartilage, connective tissues, tendons and ligaments, inflammatory diseases of muscle tissues, inflammatory diseases of the eyes, inflammatory diseases of the middle and inner ear, inflammatory diseases of the nasal and paranasal passages and sinuses, single gene disorders, bone and blood diseases, reproductive system disorders, asthma, atopic eczema, psoriasis, bronchospasm, venous thrombotic disorders, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout and macular degeneration, fungal infection; pharmaceuticals for the treatment of osteoarthritis, oncology, cardiovascular disease, respiratory disease, inflammation, namely, inflammatory joint diseases, inflammatory skin diseases, inflammatory diseases affecting articulating cartilage, connective tissues, tendons and ligaments, inflammatory diseases of muscle tissues, inflammatory diseases of the eyes, inflammatory diseases of the middle and inner ear, inflammatory diseases of the nasal and paranasal passages and sinuses, viral infection, gastrointestinal diseases and central nervous system diseases; diagnostic preparations for medical and topical use in the fields of oncology, cardiovascular disease, respiratory disease, gastro-intestinal diseases, osteoarthritis, rheumatism, inflammatory diseases, namely inflammatory joint diseases, inflammatory skin diseases, inflammatory diseases affecting articulating cartilage, connective tissues, tendons and ligaments, inflammatory of muscle tissues, inflammatory diseases of the eyes, inflammatory diseases of the middle and inner ear, inflammatory diseases of the nasal and paranasal passages and sinuses, single gene disorders, bone and blood diseases, reproductive system disorders, asthma, atopic eczema, psoriasis, bronchospasm, venous thrombotic disorders, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout or macular degeneration, and fungal infection; topical and parenteral preparations of vesicles for medical and veterinary purposes, namely, anti-inflammatory preparations; chemical preparations in the form of vesicles for medical and veterinary purposes, namely phospholipids in the nature of pain relief medication and anti-inflammatory preparations; chemical membranes and chemical aggregates for medical and veterinary purposes, namely, pain relief medication, anti-inflammatory preparations, and for the treatment of haemophilia disease; medicated preparations of arachidonic acids used for the treatment of inflammatory connective tissue diseases; dispersions and dry preparations of liposomal active substance carriers for pharmaceutical, cosmetic and veterinary substances, namely pain relief medication and anti-inflammatory preparations; cosmeceutical preparations for medical use in the form of anti-inflammatory preparations; local anaesthetics; steroids; anti-inflammatory drugs; lipids for topical and parenteral use in the form of pain relief medication and anti-inflammatory preparations for the upper dermal layers; medicated creams, dispersions, lotions, ointments, gels, solutions, sprays, lacquers and film forming solution for the treatment of pain or inflammation all in the nature of pain relief medication and anti-inflammatory preparations; medicated surfactants for use in the treatment of or prevention of cancer, infectious disease namely respiratory infections, eye infections, fungal skin infections, parasites, eye disease, diseases of the central nervous system [CNS] and peripheral nervous system disorders, cardiovascular disease, auto-immune diseases, inflammatory muscle and pelvic diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin pigmentation, hair and ear, bone and blood diseases and reproductive system disorders; medicated surfactants for use in the treatment of and prevention of inflammation, asthma, atopic eczema, dishydrotic hand eczema, plaque type psoriasis, seborrheic eczema, acne vulgaris, bronchospasm, atherothrombotic cardiovascular disorders, venous thrombotic disorders, pain, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal and toxicity disease, Alzheimer's disease, gout and macular degeneration, such as AMD, and fungal skin infection, and disorders related to fatty acid deficiencies; Veterinary therapeutic preparations and therapeutic pharmaceuticals in the fields of laminitis, debilitating joint diseases, bog spavin and bone spavin, bowed tendons, capped joints, curb (inflammation of the rear cannon bone below the point of hock), laminitis, navicular disease, osselets, ringbone, sesamoiditis, shoe boil, sidebone, speedy cut (namely striking of the inner lower side of the knee with the opposite limb), splints; veterinary therapeutic preparations and pharmaceuticals use in the treatment of sprains, stocking up, stringhalt, thoroughpin (swelling of the digital flexor tendon sheath), and windpuffs (swelling around the fetlock joint), arthritis and osteoarthritis, inflammation, namely, inflammatory joint diseases, inflammatory skin diseases, inflammatory diseases affecting articulating cartilage, connective tissues, tendons and ligaments, inflammatory diseases of muscle tissues, inflammatory diseases of the eyes, inflammatory diseases of the middle and inner ear, inflammatory diseases of the nasal and paranasal passages and sinuses, and diseases of the central nervous system; nitrocellulose membranes for veterinary diagnostic purposes; pharmaceuticals for the treatment of hoof fungal infections.


Classification kind code

11

Class [010]
Medical devices for topical use in allowing transcutaneous absorption for the treatment of pain; molecular filtering devices for medical use; medical, veterinary and surgical apparatus, instruments and devices, namely, surgical apparatus for the diagnosis and treatment of diseases in the field of oncology, cardiovascular disease and central nervous system diseases, medical apparatus, namely topically applied gel containing nanostructures for the treatment of pain and inflammation, apparatus for carrying out diagnostic tests for medical purposes in the fields of oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal disease, and central nervous systems diseases, namely monitors, scanners, ultrasound equipment for carrying out diagnostic tests for medical purposes in the field of oncology, cardiovascular disease, respiratory disease, gastro-intestinal diseases, osteoarthritis, rheumatism, inflammatory diseases, namely inflammatory joint diseases, inflammatory skin diseases, inflammatory diseases affecting articulating cartilage, connective tissues, tendons and ligaments, inflammatory of muscle tissues, inflammatory diseases of the eyes, inflammatory diseases of the middle and inner ear, inflammatory diseases of the nasal and paranasal passages and sinuses, single gene disorders, bone and blood diseases, reproductive system disorders, asthma, atopic eczema, psoriasis, bronchospasm, venous thrombotic disorders, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout or macular degeneration, fungal infection, injection syringes, medical thermometers, blood sugar meters, stents, x-ray apparatus for medical use; injection apparatus, instruments and devices, namely, injection needles for medical use, injection syringes, and injectors for medical purposes; apparatus, instruments and devices for dispensing medical, surgical and veterinary preparations, dispersions, creams, powders, tablets and pills, namely, pill dispensers for medical purposes, pharmaceutical containers especially made for storing medicines, and medical tubing for dispensing dispersions and creams; instruments and devices for the administration of therapy and prophylaxis preparations and substances, namely, surgical and medical apparatus for delivering prophylaxis and delivering prophylactic substances, and for the diagnosis and treatment of diseases, in the field of oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal disease, central nervous systems diseases, osteoarthritis, rheumatism, inflammatory joint diseases, inflammatory skin diseases, inflammatory diseases affecting articulating cartilage, connective tissues, tendons and ligaments, inflammatory of muscle tissues, inflammatory diseases of the eyes, inflammatory diseases of the middle and inner ear, inflammatory diseases of the nasal and paranasal passages and sinuses, single gene disorders, bone and blood diseases, reproductive system disorders, asthma, atopic eczema, psoriasis, bronchospasm, venous thrombotic disorders, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout or macular degeneration, and fungal infection; molecular filtering devices for veterinary use; veterinary devices for the treatment of laminitis and debilitating joint diseases, bog spavin and bone spavin, bowed tendons, capped joints, curb (inflammation of the rear cannon bone below the point of hock), laminitis, navicular disease, osselets, ringbone, sesamoiditis, shoe boil, sidebone, speedy cut (namely striking of the inner lower side of the knee with the opposite limb), splints; veterinary devices for the treatment of sprains, stocking up, stringhalt, thoroughpin (swelling of the digital flexor tendon sheath), and windpuffs (swelling around the fetlock joint), arthritis and osteoarthritis, inflammation and diseases of the central nervous system; veterinary devices for the administration of pain relief, therapy and prophylaxis, namely, surgical and medical apparatus for delivering prophylaxis and delivering prophylactic substances.


Classification kind code

11

Mark Details


Serial Number

2092548

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 21st Sep 2022
Agent Changed
Submitted for opposition 22
on 12th Jul 2022
Search Recorded
Submitted for opposition 20
on 12th Jul 2022
Examiner's First Report
Submitted for opposition 223
on 12th Jul 2022
Total Provisional Refusal
Submitted for opposition 256
on 18th Jan 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 18th Mar 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 17th Mar 2021
Formalized
Submitted for opposition 1
on 17th Mar 2021
Created
Submitted for opposition 228
on 16th Oct 2020
International Registration
Submitted for opposition 30
on 16th Oct 2020
Filed